These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38631685)

  • 41. Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma.
    Yang X; Ni H; Lu Z; Zhang J; Zhang Q; Ning S; Qi L; Xiang B
    BMC Cancer; 2023 Jan; 23(1):10. PubMed ID: 36600214
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation between the expression of CD24 on circulating tumor cells and prognosis in breast cancer.
    Zhou M; Xie P; Chen L; Zhang P; Xu F
    Am J Transl Res; 2023; 15(3):1941-1952. PubMed ID: 37056857
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preoperative Folate Receptor-Positive Circulating Tumor Cell Level Is a Prognostic Factor of Long Term Outcome in Non-Small Cell Lung Cancer Patients.
    Li H; Li B; Pan Y; Zhang Y; Xiang J; Zhang Y; Sun Y; Yu X; He W; Hu H
    Front Oncol; 2020; 10():621435. PubMed ID: 33585249
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
    Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
    Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab.
    Guibert N; Delaunay M; Lusque A; Boubekeur N; Rouquette I; Clermont E; Mourlanette J; Gouin S; Dormoy I; Favre G; Mazieres J; Pradines A
    Lung Cancer; 2018 Jun; 120():108-112. PubMed ID: 29748004
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of sensitivity and specificity of CanPatrol™ technology for detection of circulating tumor cells in patients with non-small cell lung cancer.
    Li J; Liao Y; Ran Y; Wang G; Wu W; Qiu Y; Liu J; Wen N; Jing T; Wang H; Zhang S
    BMC Pulm Med; 2020 Oct; 20(1):274. PubMed ID: 33081780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation between the presence of circulating tumor cells and the pathologic type and staging of non-small cell lung cancer during the early postoperative period.
    Xie Z; Gao X; Cheng K; Yu L
    Oncol Lett; 2017 Nov; 14(5):5825-5830. PubMed ID: 29113213
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD47 Expression in Circulating Tumor Cells and Circulating Tumor Microemboli from Non-Small Cell Lung Cancer Patients Is a Poor Prognosis Factor.
    Torres JA; Brito ABC; Silva VSE; Messias IM; Braun AC; Ruano APC; Buim MEC; Carraro DM; Chinen LTD
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569332
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circulating Tumor Cells Predict Prognosis Following Tyrosine Kinase Inhibitor Treatment in EGFR-Mutant Non-Small Cell Lung Cancer Patients.
    Yang B; Qin A; Zhang K; Ren H; Liu S; Liu X; Pan X; Yu G
    Oncol Res; 2017 Nov; 25(9):1601-1606. PubMed ID: 28474575
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Frequency of Circulating Tumor Cells (CTC) in Patients with Brain Metastases: Implications as a Risk Assessment Marker in Oligo-Metastatic Disease.
    Hanssen A; Riebensahm C; Mohme M; Joosse SA; Velthaus JL; Berger LA; Bernreuther C; Glatzel M; Loges S; Lamszus K; Westphal M; Riethdorf S; Pantel K; Wikman H
    Cancers (Basel); 2018 Dec; 10(12):. PubMed ID: 30572662
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aneuploid Circulating Tumor Cells as a Predictor of Response to Neoadjuvant Chemotherapy in Non-Small Cell Lung Cancer.
    Huang M; Ma Y; Lv C; Li S; Lu F; Zhang S; Wang DD; Lin PP; Yang Y
    Int J Gen Med; 2021; 14():6609-6620. PubMed ID: 34703281
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monitoring with circulating tumor cells in the perioperative setting of patients with surgically treated stages I-IIIA NSCLC.
    Garitaonaindia Y; Aguado-Noya R; Garcia-Grande A; Cordoba M; Coronado Albi MJ; Campo Cañaveral JL; Calvo V; Clemente MB; Álvarez R; Peñas M; Chara L; Royuela A; Provencio M
    Transl Lung Cancer Res; 2023 Jul; 12(7):1414-1424. PubMed ID: 37577300
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and prognostic significance of detecting
    Rehulkova A; Chudacek J; Prokopova A; Vidlarova M; Stranska J; Drabek J; Potockova J; Trojanec R; Vrbkova J; Skarda J; Bohanes T; Szkorupa M; Tolmaci B; Klein J; Srovnal J; Hajduch M
    Transl Lung Cancer Res; 2023 May; 12(5):1034-1050. PubMed ID: 37323172
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficient isolation and quantification of circulating tumor cells in non-small cell lung cancer patients using peptide-functionalized magnetic nanoparticles.
    Liang N; Liu L; Li P; Xu Y; Hou Y; Peng J; Song Y; Bing Z; Wang Y; Wang Y; Jia Z; Yang X; Li D; Xu H; Yu Q; Li S; Hu Z; Yang Y
    J Thorac Dis; 2020 Aug; 12(8):4262-4273. PubMed ID: 32944338
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Leukapheresis increases circulating tumour cell yield in non-small cell lung cancer, counts related to tumour response and survival.
    Tamminga M; Andree KC; van den Bos H; Hiltermann TJN; Mentink A; Spierings DCJ; Lansdorp P; Timens W; Schuuring E; Terstappen LWMM; Groen HJM
    Br J Cancer; 2022 Feb; 126(3):409-418. PubMed ID: 34848855
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation between Circulating Tumor Cells and Plasma D-dimer and Clinicopathological Characteristics of Patients with Non-small Cell Lung Cancer.
    Wang J; Liu H; Sun X; Liu Q; Han S; Zhu L
    J Coll Physicians Surg Pak; 2021 Apr; 31(4):417-421. PubMed ID: 33866727
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical significance of epithelial-mesenchymal transition typing of circulating tumour cells in colorectal cancer.
    Hou J; Guo C; Lyu G
    Colorectal Dis; 2020 May; 22(5):581-587. PubMed ID: 31868956
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy.
    Zhang D; Zhao L; Zhou P; Ma H; Huang F; Jin M; Dai X; Zheng X; Huang S; Zhang T
    Cancer Cell Int; 2017; 17():6. PubMed ID: 28070168
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of Cell Surface Vimentin Positive Circulating Tumor Cells as a Diagnostic Biomarker for Lung Cancer.
    Xie X; Wang L; Wang X; Fan WH; Qin Y; Lin X; Xie Z; Liu M; Ouyang M; Li S; Zhou C
    Front Oncol; 2021; 11():672687. PubMed ID: 34055642
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A prospective examination of circulating tumor cell profiles in non-small-cell lung cancer molecular subgroups.
    Lindsay CR; Faugeroux V; Michiels S; Pailler E; Facchinetti F; Ou D; Bluthgen MV; Pannet C; Ngo-Camus M; Bescher G; Caramella C; Billiot F; Remon J; Planchard D; Soria JC; Besse B; Farace F
    Ann Oncol; 2017 Jul; 28(7):1523-1531. PubMed ID: 28633480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.